| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/06/2002 | WO2002046216A3 Human sprouty-4 polypeptide |
| 09/06/2002 | WO2002036817A3 Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis |
| 09/06/2002 | WO2002036771A3 Imaging, diagnosis and treatment of disease |
| 09/06/2002 | WO2002032931A3 Haplotypes of the fos gene |
| 09/06/2002 | WO2002031482A3 Device and method for electrically accelerated immobilisation of molecules |
| 09/06/2002 | WO2002031182A3 Method and apparatus for reading reporter labeled beads |
| 09/06/2002 | WO2002030952A3 Haplotypes of the cyp27a1 gene |
| 09/06/2002 | WO2002029004A3 Haplotypes of the smoh gene |
| 09/06/2002 | WO2002020842A8 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 09/06/2002 | WO2002016574A3 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 09/06/2002 | WO2002012901A3 Use of grf1 protein for screening molecules |
| 09/06/2002 | WO2002012554A3 Diagnosis of diseases which are associated with cd24 |
| 09/06/2002 | WO2002010217A3 Endothelial cell expression patterns |
| 09/06/2002 | WO2002008449A3 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/06/2002 | WO2002004672A3 Diagnostic method for the identification of foetal dna in a maternal sample |
| 09/06/2002 | WO2002002629A3 Grf2-binding proteins and applications thereof |
| 09/06/2002 | WO2001094612A3 Method for identifying medically valuable active substances |
| 09/06/2002 | WO2001092570A3 Method to screen for improved meat characteristics in pigs |
| 09/06/2002 | WO2001092565A3 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 09/06/2002 | WO2001092562A3 Inhibiting retroviral integration by targeting the atm pathway |
| 09/06/2002 | WO2001092479A3 Method to determine the differentiation potential of a target cell |
| 09/06/2002 | WO2001091805A3 Compounds for targeting endothelial cells |
| 09/06/2002 | WO2001085785A3 Ph domain-interacting protein |
| 09/06/2002 | WO2001079287A3 Steatosis-modulating factors and uses thereof |
| 09/06/2002 | WO2001077380A3 Method for predicting predisposition to a disease associated with mutations in a rpgr gene |
| 09/06/2002 | WO2001072995A3 Methods of producing a library and methods of selecting polynucletides |
| 09/06/2002 | WO2001072822B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/06/2002 | WO2001062965A3 Differential expression screening method |
| 09/06/2002 | WO2001061038A3 Method for detecting a biological entity in a sample |
| 09/06/2002 | WO2001051664A3 Method of detecting and characterizing a neoplasm |
| 09/06/2002 | WO2001048485A9 Selecting library members capable of binding to epitopes |
| 09/06/2002 | WO2001048247A3 METHOD FOR GENERATION OF LONGER cDNA FRAGMENTS FROM SAGE TAGS FOR GENE IDENTIFICATION |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001031021A9 Multiple sclerosis-related superantigen |
| 09/06/2002 | WO2001024681A9 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 09/06/2002 | WO2001023606A3 Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria |
| 09/06/2002 | WO2001018546A9 Screening for inhibitors of 'paired helical filaments' |
| 09/06/2002 | WO2001018524A9 Methods for improving signal detection from an array |
| 09/06/2002 | WO2001018233A9 Screening for inhibitors of lumazine synthase |
| 09/06/2002 | WO2001018035A9 Muc-1 derived peptides |
| 09/06/2002 | WO2001014581A9 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 09/06/2002 | WO2001009591A9 Method for optical excitation of fluorophore marked dna and rna |
| 09/06/2002 | WO2001006249A9 Organic semiconductor recognition complex and system |
| 09/06/2002 | WO2001005944A9 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/06/2002 | WO2000078955A9 Epithelial cell growth inhibitors |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | WO2000065062A9 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 09/06/2002 | CA2846761A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | CA2833423A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2477043A1 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | CA2444493A1 Method for identifying biologically active structures of microbial pathogens |
| 09/06/2002 | CA2439830A1 Determining the risk of caries in a patient |
| 09/06/2002 | CA2439477A1 Circular probe amplification (cpa) using energy-transfer primers |
| 09/06/2002 | CA2439403A1 Method for evaluating the ability to metabolize pharmaceuticals and compositions therefor |
| 09/06/2002 | CA2439400A1 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | CA2439332A1 Diagnostic test for the detection of chromosomal abnormalities in a fetus |
| 09/06/2002 | CA2439307A1 Methods for providing extended dynamic range in analyte assays |
| 09/06/2002 | CA2439303A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | CA2439279A1 Chemokine receptors and disease |
| 09/06/2002 | CA2438884A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2438832A1 Transgenic knockouts of bace-1 |
| 09/06/2002 | CA2438798A1 Biosynthesis of polyketide synthase substrates |
| 09/06/2002 | CA2438757A1 Determining cartilage degeneration and aging using bone morphogenic proteins |
| 09/06/2002 | CA2438680A1 Genes encoding proteolytic enzymes from aspargilli |
| 09/06/2002 | CA2438406A1 Materials and methods for the induction of premature chromosome condensation |
| 09/06/2002 | CA2438212A1 Biosensor for detecting chemical agents |
| 09/06/2002 | CA2438205A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2434679A1 Beta-lactamase substrates having phenolic ethers |
| 09/06/2002 | CA2433474A1 70 human secreted proteins |
| 09/06/2002 | CA2432029A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | CA2430192A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/05/2002 | US20020124273 Protein-protein interactions in neurodegenerative diseases |
| 09/05/2002 | US20020123847 Method for analyzing biological elements |
| 09/05/2002 | US20020123634 Asymmetric derivatives of furamidines; contacting the sample DNA with above compound |
| 09/05/2002 | US20020123620 Method of determining dihydropyrimidine dehydrogenase gene expression |
| 09/05/2002 | US20020123517 Method for controlling cell necrosis or apoptosis |
| 09/05/2002 | US20020123481 C-fos induced growth factor (FIGF) and DNA encoding same |
| 09/05/2002 | US20020123474 Human GTP-Rho binding protein2 |
| 09/05/2002 | US20020123463 As diagnostics, biosensors and bioreactors, pharmaceuticals |
| 09/05/2002 | US20020123456 Inhibiting atrophy or inducing hypertrophy in skeletal muscle cells comprising treating the cells with an inhibitor of the SHIP2 pathway |
| 09/05/2002 | US20020123454 Assaying ability of compound to modulate a NT69 nucleic acid expression or NT69 polypeptide activity, thereby identifying a compound capable of treating a pain disorder |
| 09/05/2002 | US20020123427 Plant phosphomevalonate kinases |
| 09/05/2002 | US20020123156 Liquid processing method making use of pipette device and apparatus for same |
| 09/05/2002 | US20020123132 Apparatus for use in the analysis of nucleotide and protein sequences |
| 09/05/2002 | US20020123120 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123115 Nucleotide sequences coding enzymatic polypeptide for use in detection and treatment of cancer |
| 09/05/2002 | US20020123113 Genetically adjusted fluorescent protein for use as detection tool genetic engineering |
| 09/05/2002 | US20020123110 Deprotecting a hydroxide or amine; obtain sample, incubate with enzyme, remoe protecting group, recover amine |
| 09/05/2002 | US20020123102 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of thyroid defcets |
| 09/05/2002 | US20020123099 Highly expressible genes |
| 09/05/2002 | US20020123096 Dopamine receptors and genes |
| 09/05/2002 | US20020123095 Estrogen receptor alpha variants and methods of detection thereof |
| 09/05/2002 | US20020123091 Composition for use in the diagnosis, prevention and treatment of cardiovascular, endothelial or angiogenic disorders in mammals |
| 09/05/2002 | US20020123089 System for detecting sterilization effectiveness |
| 09/05/2002 | US20020123088 Method of measuring total homocysteine |
| 09/05/2002 | US20020123087 Biocompatible membrane; for use in the measurement of particles in a tissue |
| 09/05/2002 | US20020123086 Method to distinguish whether an event sequence is a memory driven event sequence or is not a memory driven event sequence |